International Biotechnology Trust (LSE:IBT) Capex-to-Operating-Cash-Flow : 0.00 (As of Feb. 2024)

International Biotechnology Trust Capex-to-Operating-Cash-Flow Chart

International Biotechnology Trust Annual Data
	Trend	Aug14	Aug15	Aug16	Aug17	Aug18	Aug19	Aug20	Aug21	Aug22	Aug23
Capex-to-Operating-Cash-Flow		Get a 7-Day Free Trial					-	-	-	-	-

International Biotechnology Trust Semi-Annual Data
	Aug14	Feb15	Aug15	Feb16	Aug16	Feb17	Aug17	Feb18	Aug18	Feb19	Aug19	Feb20	Aug20	Feb21	Aug21	Feb22	Aug22	Feb23	Aug23	Feb24
Capex-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of International Biotechnology Trust's Capex-to-Operating-Cash-Flow

For the Biotechnology subindustry, International Biotechnology Trust's Capex-to-Operating-Cash-Flow, along with its competitors' market caps and Capex-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

International Biotechnology Trust's Capex-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, International Biotechnology Trust's Capex-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where International Biotechnology Trust's Capex-to-Operating-Cash-Flow falls into.

International Biotechnology Trust Capex-to-Operating-Cash-Flow Calculation

International Biotechnology Trust's Capex-to-Operating-Cash-Flow for the fiscal year that ended in Aug. 2023 is calculated as

International Biotechnology Trust's Capex-to-Operating-Cash-Flow for the quarter that ended in Feb. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

International Biotechnology Trust  (LSE:IBT) Capex-to-Operating-Cash-Flow Explanation

Capex-to-Operating-Cash-Flow ratio assesses how much of a company’s Cash Flow from Operations is being devoted to Capital Expenditure. It is a good indicator in terms of how much the company is focused on growth. In general, a high Capex-to-Operating-Cash-Flow ratio indicates that the company is investing more in physical assets and is focused on growth and expansion. Conversely, lower ratio could indicate that a company has reached maturity and is no longer pursuing aggressive growth.

Moreover, the ratio is also useful to distinguish whether the company is capital intensive or not. If the ratio is large, then the company tends to be capital intensive. Lower ratio suggests that it’s a capital-light business. The ratio can be combined with ROIC % to identify whether the company is an asset-light business that has a high return on invested capital. This is one question investors commonly ask to see if a company qualifies as a good company.

International Biotechnology Trust Capex-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of International Biotechnology Trust's Capex-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

International Biotechnology Trust (LSE:IBT) Business Description